Track Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's EBIT ($-19M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025
The latest EBIT for OTRKP is $-19M as of March 2025. That compares with $-18M in the prior-year period — down 8.5% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.
Over the past year, OTRKP's EBIT moved from $-18M to $-19M — a 8.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's operating scale or balance-sheet position.
Against Healthcare companies, OTRKP currently prints $-19M for EBIT, while the sector average sits near $23B. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's growth, margins, and balance sheet.
A EBIT figure of $-19M for OTRKP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.
After noting OTRKP's EBIT ($-19M), review year-over-year change from $-18M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.